Semaglutide boosts kidney outcomes with obesity + cardiovascular disease
May 28, 2024
At the prespecified 104-week time point, semaglutide was associated with a lesser decline in eGFR than placebo.
One in five seniors report cost-related medication nonadherence
May 18, 2023
Most respondents indicated a desire for use of a real-time benefit tool, with concern reported regarding inaccurate prices.
Warfarin cuts mortality, thromboembolism after valve replacement
Jan 04, 2024
Warfarin, however, was tied to an increased risk for major bleeding events.
Subcutaneous infusion of levodopa-carbidopa beneficial for Parkinson’s disease
Apr 11, 2024
The infusion increases on time without troublesome dyskinesia and reduces daily off time.
Antidepressant augmentation examined in seniors with depression
Mar 06, 2023
An improvement in well-being and remission was seen with aripiprazole-augmentation of existing antidepressants.
Oldest adults with acute myeloid leukemia benefit from Venetoclax
May 16, 2024
Octogenarians and nonagenarians can be treated successfully with VEN-HMA.
ACP: Next-generation antibiotics underused for gram-negative infections
Apr 22, 2024
41.5% of difficult-to-treat resistance episodes were treated exclusively with traditional agents.
Glycemic control superior with semaglutide 25 and 50 mg in Type 2 diabetes
Aug 04, 2023
Mean changes in HbA1c were significantly greater for semaglutide 25 mg or 50 mg versus 14 mg.
CMS announces Alzheimer’s drug coverage policy, but ‘the devil is in the details,’ experts say
By
Kimberly Bonvissuto
Jun 01, 2023
A Thursday announcement by the Centers for Medicare & Medicaid Services regarding coverage of Alzheimer’s drugs is being met with skepticism by some industry advocates who say that “the devil is in...
Focus on briefs: Resident security
By
John Hall
Dec 03, 2023
Costs, along with changing attitudes, help fuel growth in deprescribing, Older Americans have access to more vaccines than ever, but increasing numbers cause concern for some individuals